LYEL — Lyell Immunopharma, Inc. | XLV Holdings | StockAdder

(LYEL)

Lyell Immunopharma, Inc.

Live chart and latest LYEL stock news.

Sector ETF → XLV Health Care Select

Chart powered byTradingView— professional charts for every trader.Try it free →

LYEL News

[EFFECT] Lyell Immunopharma, Inc. SEC Filing

Apr 15, 2026 ChartMill

LYEL Earnings History & Surprises | EPS & Revenue Results | LYELL IMMUNOPHARMA INC (NASDAQ:LYEL)

Apr 10, 2026 Yahoo Finance

Institutional investors are Lyell Immunopharma, Inc.'s (NASDAQ:LYEL) biggest bettors and were rewarded after last week's US$72m market cap gain

Dec 17, 2025 Zacks Investment Research

Should I buy Lyell Immunopharma (LYEL)

Dec 24, 2025 simplywall.st

Lyell Immunopharma, Inc.'s (NASDAQ:LYEL) one-year returns climbed after last week's 13% gain, institutional investors must be happy

Nov 22, 2025 Seeking Alpha

Lyell Immunopharma: Strong Early CAR-T Data, And Now A More Measured Bet (NASDAQ:LYEL)

Mar 23, 2026 Stock Titan

Cancer drug developer Lyell will webcast a management presentation Apr. 14

Apr 7, 2026 TradingView — Track All Markets

Lyell Immunopharma, Inc. Financial Disclosures & SEC Filings

Sep 13, 2025 GlobeNewswire

Lyell Immunopharma Announces up to $100 Million Equity Private Placement

Jul 25, 2025 Stock Titan

Lyell Immunopharma registers 1.95M shares for resale (NASDAQ: LYEL)

Apr 3, 2026 Seeking Alpha

Lyell Immunopharma: LYL314 Drives Momentum Amid Strong ASH Data (NASDAQ:LYEL)

Dec 24, 2025 Stock Titan

Cancer therapy developer Lyell to join three investor conferences in March

Feb 23, 2026 Seeking Alpha

Lyell Immunopharma buys exclusive global rights to colorectal cancer drug

Nov 10, 2025 Stock Titan

Cancer cell therapy milestone brings Lyell $50M cash boost and new CFO

Mar 9, 2026 Stock Titan

Lyell Immunopharma (LYEL) grants CFO 140,000 stock options